RVLP
Geode Capital Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-307,266
| Closed | -$26.6K | – | 4787 |
|
|
2023
Q3 | $26.6K | Hold |
307,266
| – | – | ﹤0.01% | 4568 |
|
|
2023
Q2 | $172K | Hold |
307,266
| – | – | ﹤0.01% | 4105 |
|
|
2023
Q1 | $350K | Hold |
307,266
| – | – | ﹤0.01% | 3789 |
|
|
2022
Q4 | $344K | Buy |
307,266
+2,884
| +0.9% | +$3.23K | ﹤0.01% | 3841 |
|
|
2022
Q3 | $639K | Buy |
304,382
+41,605
| +16% | +$87.3K | ﹤0.01% | 3597 |
|
|
2022
Q2 | $357K | Buy |
262,777
+9,692
| +4% | +$13.2K | ﹤0.01% | 3945 |
|
|
2022
Q1 | $427K | Buy |
253,085
+109,423
| +76% | +$185K | ﹤0.01% | 4018 |
|
|
2021
Q4 | $155K | Sell |
143,662
-2,770
| -2% | -$2.99K | ﹤0.01% | 4587 |
|
|
2021
Q3 | $431K | Sell |
146,432
-9,286
| -6% | -$27.3K | ﹤0.01% | 4101 |
|
|
2021
Q2 | $468K | Sell |
155,718
-85,013
| -35% | -$256K | ﹤0.01% | 3975 |
|
|
2021
Q1 | $784K | Buy |
240,731
+14,695
| +7% | +$47.9K | ﹤0.01% | 3656 |
|
|
2020
Q4 | $931K | Buy |
226,036
+7,101
| +3% | +$29.2K | ﹤0.01% | 3386 |
|
|
2020
Q3 | $1.18M | Sell |
218,935
-449
| -0.2% | -$2.43K | ﹤0.01% | 3141 |
|
|
2020
Q2 | $1.48M | Buy |
219,384
+15,400
| +8% | +$104K | ﹤0.01% | 3004 |
|
|
2020
Q1 | $648K | Buy |
203,984
+66,058
| +48% | +$210K | ﹤0.01% | 3189 |
|
|
2019
Q4 | $964K | Buy |
137,926
+32,740
| +31% | +$229K | ﹤0.01% | 3289 |
|
|
2019
Q3 | $403K | Buy |
105,186
+284
| +0.3% | +$1.09K | ﹤0.01% | 3543 |
|
|
2019
Q2 | $398K | Buy |
104,902
+12,593
| +14% | +$47.8K | ﹤0.01% | 3551 |
|
|
2019
Q1 | $332K | Buy |
92,309
+5,993
| +7% | +$21.6K | ﹤0.01% | 3582 |
|
|
2018
Q4 | $668K | Buy |
+86,316
| New | +$668K | ﹤0.01% | 3261 |
|